Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

(2011) A. Curti et al.   BLOOD

Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma

(2011) Madhavi Challa-Malladi et al.   CANCER CELL

Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands

(2011) Beatriz Sanchez-Correa et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies

(2011) Garnet Suck et al.   EXPERIMENTAL HEMATOLOGY

Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia

(2011) Régis T. Costello et al.   IMMUNOLOGY

Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients

(2011) Beatriz Sanchez-Correa et al.   IMMUNOLOGY AND CELL BIOLOGY

Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells

(2011) Benny Weiss-Steider et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity

(2011) Erica B. Wilson et al.   PLoS One

Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?

(2010) Roel Willemze et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity

(2010) C. J. Sanchez et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

(2010) Jeffrey E. Rubnitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report

(2010) Stacey L. Berg et al.   JOURNAL OF CLINICAL ONCOLOGY

Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses

(2010) X. Zhang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate

(2009) A Poggi et al.   LEUKEMIA

Post-consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML

(2009) A. I. Romero et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Natural killer and γδ T cells in haematological malignancies: enhancing the immune effectors

(2009) Jérôme Rey et al.   TRENDS IN MOLECULAR MEDICINE

Induction of MHC class I-related chain B (MICB) by 5-aza-2′-deoxycytidine

(2008) Kai-Fu Tang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

(2008) A. Soriani et al.   BLOOD

Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16

(2008) Christophe de Romeuf et al.   BRITISH JOURNAL OF HAEMATOLOGY

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

(2008) Jumei Shi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome Inhibitors

(2008) M. Vales-Gomez et al.   CANCER RESEARCH

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G

(2008) G Maki et al.   LEUKEMIA

Does chemotherapy modify the immune surveillance of hematological malignancies?

(2008) A J Barrett et al.   LEUKEMIA

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-γ secretion by human NK cells

(2008) Eva Lion et al.   LEUKEMIA RESEARCH

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

(2008) M. Jinushi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA